After more than a decade, there is renewed interest in Metabolic Syndrome — a disastrous clustering of abnormalities that may include obesity, hyperglycemia, visceral adiposity, high blood pressure, and atherogenic dyslipidemia. New insights have emerged with regard to risk, pathology and related biomarkers, as well as new management strategies. Gain insights into the cause of this deadly metabolic disruption, evidence-based and novel interventions, risk assessment, and diagnostic pearls.

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP; Founder and Nurse Practitioner, Metabolic Medicine Associates; King George VA